We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Miragen Therapeutics Inc | NASDAQ:MGEN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 23.01 | 23.01 | 23.95 | 0 | 01:00:00 |
Delaware | 001-36483 | 47-1187261 | ||||||||||||
(State or other jurisdiction
of incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
6200 Lookout Rd. | |||||||||||||||||
Boulder, | CO | 80301 | |||||||||||||||
(Address of principal executive offices) | (Zip Code) |
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||||
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class |
Trading
Symbol(s) |
Name of each exchange
on which registered |
|||||||||||||||
Common Stock, $0.01 par value | VRDN | The Nasdaq Stock Market LLC |
Exhibit Number | Exhibit Description | |||||||
Open Market Sale Agreement, dated April 23, 2021, by and between Viridian Therapeutics, Inc. and Jefferies LLC. | ||||||||
Opinion of Gibson, Dunn & Crutcher LLP. | ||||||||
Consent of Gibson, Dunn & Crutcher LLP (contained in Exhibit 5.1). | ||||||||
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |||||||
Viridian Therapeutics, Inc. | |||||||||||||||||
Date: April 23, 2021 | By: | /s/ Jason A. Leverone | |||||||||||||||
Jason A. Leverone | |||||||||||||||||
Chief Financial Officer, Treasurer, and Secretary |
1 Year Miragen Therapeutics Chart |
1 Month Miragen Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions